Cristalia

Cristália is a leading Brazilian pharmaceutical company that excels in the complete medication chain, with a particular focus on anesthetics and narcoanalgesics in Latin America. With a robust portfolio of 107 granted patents and 209 pending applications globally, Cristália is at the forefront of the market for anesthetics and allied products in the region. The company operates through six sites situated in Brazil and Argentina, exporting its products, which include anti-AIDS, psychiatric, pain management, oncology, and biotechnology finished dosages and active pharmaceutical ingredients (APIs), to more than 30 countries.

Services include:
- Finished Dosage Forms
- Active Pharmaceutical Ingredients (APIs)
- Research and Development
- Regulatory Affairs
- Quality Assurance
- Export and Distribution

Cristália remains committed to innovation and excellence within the pharmaceutical industry, ensuring high-quality products and services that cater to the evolving needs of healthcare. For more information, please visit cristalia.com.br.